Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.

Citation:
Vazhappilly CG, S. E, Ramadan W, Menon V, Al-Azawi AM, Tarazi H, Abdu-Allah H, El-Shorbagi AN, and E. - A. R., "Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.", Invest New Drugs. 2019 , vol. 37(2), pp. 252-261, 2019.
PreviewAttachmentSize
invest_new_drugs_1.pdf3.6 MB